Characteristics and Outcome of 110 Patients with Recurrent HNSCC
| Characteristic | Data |
| Age (y) | |
| Median | 66 |
| Range | 40–87 |
| Sex | |
| Male | 90 (82) |
| Female | 20 (18) |
| Initial primary tumor site | |
| Oral cavity | 17 (15) |
| Pharynx | 56 (51) |
| Larynx | 37 (34) |
| Primary stage | |
| I | 15 (14) |
| II | 20 (18) |
| III | 19 (17) |
| IVA | 44 (40) |
| IVB | 12 (11) |
| IVC | 0 (0) |
| Human papillomavirus status | |
| Negative | 72 (65) |
| Positive | 38 (35) |
| Primary N-classification | |
| N0 | 60 (55) |
| N+ | 50 (45) |
| Primary treatment | |
| Surgery | 8 (7) |
| Surgery + radiotherapy | 10 (9) |
| Radiotherapy | 68 (62) |
| Chemoradiotherapy | 24 (22) |
| Follow-up (d)* | |
| Median | 491 |
| Range | 13–1,505 |
| Cancer-specific mortality | |
| Overall | 63/110 (57) |
| Oral cavity | 9/17 (53) |
| Pharynx | 35/56 (63) |
| Larynx | 19/37 (51) |
↵* From diagnosis of recurrence.
Qualitative data are expressed as numbers followed by percentages in parentheses; continuous data are expressed as median and range.